OGTT Recommendations for Diabetes Diagnosis

Diagnostic Thresholds and Equivalence of Testing Methods

The American Diabetes Association (ADA) states that the oral glucose tolerance test (OGTT) is an appropriate and equivalent screening option to fasting plasma glucose and HbA1c for diagnosing diabetes and prediabetes; diagnostic thresholds are ≥200 mg/dL (≥11.1 mmol/L) at 2 hours for diabetes and 140–199 mg/dL (7.8–11.0 mmol/L) for impaired glucose tolerance (IGT). 1
The ADA defines diabetes diagnostic criteria as: 2‑hour plasma glucose ≥200 mg/dL, fasting plasma glucose ≥126 mg/dL (≥7.0 mmol/L), or HbA1c ≥6.5% (≥48 mmol/mol). 1, 2
Prediabetes is identified by: 2‑hour plasma glucose 140–199 mg/dL, fasting plasma glucose 100–125 mg/dL (5.6–6.9 mmol/L), or HbA1c 5.7–6.4% (39–47 mmol/mol). 1

To avoid falsely low OGTT results, patients should consume at least 150 g of carbohydrate per day for the three days preceding the test. 1

The European Society of Cardiology (ESC) recommends OGTT when fasting plasma glucose and HbA1c are inconclusive or borderline. 2, 3
ESC also advises OGTT to diagnose IGT, which cannot be detected by fasting glucose or HbA1c alone. 2, 3
OGTT is particularly valuable in patients with cardiovascular disease, as it detects significantly more cases of diabetes and prediabetes than fasting glucose or HbA1c alone. 2, 3
Women with a prior history of gestational diabetes should undergo OGTT for diabetes screening. 1

The ADA recommends screening all adults who are overweight (BMI ≥ 25 kg/m², or ≥ 23 kg/m² in Asian individuals) and have at least one additional risk factor. 1, 4
All other adults should begin screening at age 35 years. 1, 4
Children and adolescents who are overweight (BMI ≥ 85th percentile) or obese (BMI ≥ 95th percentile) and have risk factors should be screened starting at puberty or age 10 years. 1, 4

First‑degree relative with diabetes.
History of cardiovascular disease.
Hypertension (≥ 130/80 mmHg or on therapy).
Low HDL (< 35 mg/dL) and/or high triglycerides (> 250 mg/dL).
Polycystic ovary syndrome.
Physical inactivity.
Use of glucocorticoids, statins, thiazide diuretics, or certain HIV medications.
[All cited: 1, 4]

Annual retesting is required for people with prediabetes (IGT or IFG). 1, 4
Intensive lifestyle modification—including modest weight loss and regular moderate‑intensity exercise (e.g., walking)—has been shown to prevent progression to diabetes. 5

In acute coronary syndromes, OGTT should be delayed 4–5 days to minimize false‑positive results. 2

The ADA considers fasting plasma glucose, the 2‑hour OGTT, and HbA1c to be equally appropriate for diabetes screening, recognizing that each assesses different physiological pathways and identifies distinct at‑risk populations. 1, 4

The American Diabetes Association recommends OGTT to diagnose diabetes mellitus, impaired glucose tolerance (IGT), and impaired fasting glucose (IFG) in patients with inconclusive fasting plasma glucose and HbA1c results 6, 7, 8, 9
OGTT is valuable for detecting impaired glucose tolerance (IGT), a significant risk factor for future diabetes and cardiovascular disease, with a recommended glucose load containing 75g of anhydrous glucose dissolved in water 6, 7
The European Society of Cardiology recommends OGTT for cardiovascular patients when HbA1c and fasting plasma glucose are inconclusive 8, 9

The American Diabetes Association diagnoses diabetes if 2-hour plasma glucose is ≥200 mg/dL (11.1 mmol/L) and impaired glucose tolerance (IGT) if 2-hour plasma glucose is between 140-199 mg/dL (7.8-11.0 mmol/L) 6, 7
Impaired fasting glucose (IFG) is diagnosed if fasting plasma glucose is between 100-125 mg/dL (5.6-6.9 mmol/L) according to ADA criteria, with both IGT and IFG being risk factors for future diabetes and cardiovascular disease 6, 7

The American Diabetes Association recommends repeat testing at least at 3-year intervals if tests are normal 6, 7
In patients with pre-diabetes, other cardiovascular risk factors should be identified and treated, with laboratory measurement of plasma glucose performed on venous samples with enzymatic assay techniques 6, 7, 10
Certain medications, including glucocorticoids and nicotinic acid, may affect test results by producing hyperglycemia 10

Patients should fast for at least 8 hours prior to the test, with a baseline fasting plasma glucose sample collected and blood samples collected at specific intervals 7, 11
The 2-hour post-load sample is most critical for diagnosis, with the test performed in a healthcare setting, not as community screening 7, 12